Eilean Therapeutics
Clinical trials sponsored by Eilean Therapeutics, explained in plain language.
-
New hope for tough cancers: experimental drug ZE94-0605 enters first human tests
Disease control Not yet recruitingThis early-phase study tests an experimental drug called ZE94-0605 in about 60 adults with advanced solid tumors (like lung, ovarian, or other cancers) that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers w…
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 17, 2026 07:25 UTC
-
New drug ZE74-0282 targets rare blood cancers in early trial
Disease control Not yet recruitingThis early-stage trial tests an experimental drug, ZE74-0282, in about 60 adults with blood cancers like polycythemia vera or myelofibrosis caused by a JAK2 mutation. The main goals are to find the safest dose and check for side effects, while also seeing if the drug shows any si…
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:31 UTC